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The photochemistry and molecular structure of 1-phenyl-4-allyl-tetrazolone (PAT) was studied by
FT-IR matrix isolation spectroscopy and DFT(B3LYP)/6-311++G(d,p) calculations. The spectrum of
matrix-isolated PAT monomers agrees well with the sum spectrum of three conformers predicted
theoretically. UV irradiation (k > 235 nm) of matrix-isolated PAT induces three types of
photofragmentation: (1) production of phenylazide and allyl-isocyanate, with phenylazide then losing
N2 to yield 1-aza-1,2,4,6-cycloheptatetraene; (2) formation of phenyl-isocyanate and allylazide; (3) N2
elimination leading to formation of 1-allyl-2-phenyldiaziridin-3-one; this compound partially reacts
further to form 1-allyl-1H-benzoimidazol-2(3H)-one. The observed photochemistry of the
matrix-isolated PAT is distinct from the preferred photochemical fragmentation in solution, where
3,4-dihydro-3-phenylpyrimidin-2(1H)-one is produced as the primary photoproduct.
1. Introduction
The application of tetrazoles in ﬁelds of great relevance, such
as medicine or agriculture, is widespread and well-known. In
many drugs and drug-candidates, replacement of carboxylic acid
groups -CO2H by tetrazolic acid fragments CN4H is frequent.
Despite the similarities in physical characteristics of these two
groups, the tetrazolic acid fragment is the preferred one in several
cases due to its superior metabolic stability at physiologic pH,
and replacement of -CO2H by -CN4H typically results in an
increase in bioavailability of the pharmacophore. For instance,
the tetrazolic ring has been used to modify the structure of the
heme environment in myoglobin through incorporation of the N-
tetrazol-5-yl histidine unit,1 3′-tetrazolo-3′-deoxythymidines were
the ﬁrst approved drugs for AIDS treatment and several tetrazole
derivatives have also been explored for antituberculotic activity.2,3
5-Oxo-substituted tetrazoles, i.e., tetrazolones are particularly
stable metabolically. Tetrazolone derivatives have been used as
potent and selective agonists of the b3 human adrenergic receptors
(b3-HAR). The receptor is linked to the increase in metabolic
rates in humans and, as a result, b3-HAR agonists are useful in
the treatment of obesity. Previously developed, b3-HAR agonists
containing imidazolidinone and imidazolone rings were found
to have quite low oral bioavailability due to their extensive
metabolism. The higher stability of tetrazolone derivatives allowed
to overcome this problem.4–6
Tetrazoles also have many other applications, such as in
agriculture,7 photography and photoimaging8 and in automobile
industry as gas generating agents for airbags.9
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In view of the scientiﬁc and industrial relevance of tetrazolyl
derivatives, our research program has long been focused on the
investigation of structure–reactivity relationships in tetrazole-
based compounds. Regarding their photoreactivity, it has been
shown that tetrazole-ring cleavages, leading either to azides
or aziridines, represent the main characteristic photochemical
reactions of this family of heterocycles. However, the structure
of the starting compound and the reaction conditions strongly
determine the precise nature and relative amounts of the ﬁnal
photoproducts, making this type of compounds a permanent
challenge to research.10,11
In recent contributions we have described the photochemistry
of some representative tetrazolyl compounds isolated in low-
temperaturematrices.12–15 Thephotochemistry of a series of 4-allyl-
tetrazolones in solution16 was also addressed, and the investigation
has led to a new synthetic strategy for the one-step and high
yielding photochemical conversion of the 1-substituted-4-allyl-
tetrazol-5-ones into 3,4-dihydro-pyrimidinones, an important
class of heterocycles.17 Thus, 1,4-substituted-5-tetrazolones are
especially versatile as intermediate compounds in the synthesis
of other heterocyclic systems. Besides the already mentioned
relevance of tetrazoles, compounds bearing an allylic alcohol
function are often vital structural units of biologically active
systems, and also act as key intermediates in synthesis.18,19
4-Allyl-tetrazolones are readily obtained fromreactionof an allylic
alcohol and 5-chloro tetrazole.20,21
Basedon the above expressed considerations,we hereby describe
the results of our recent investigation on the structure and re-
activity of 4-allyl-tetrazolyl derivatives. 1-Phenyl-4-(prop-2-enyl)-
tetrazol-5-one (1-phenyl-4-allyl-tetra-zolone, PAT) was selected as
the subject of the present study. The structure of PAT monomers
isolated in low temperature inert gas matrices as well as their
UV induced photochemistry were studied by means of infrared
spectroscopy, supported by extensive DFT calculations.
The matrix isolation technique coupled to a suitable probing
method such as FT-IR spectroscopy represents a powerful ap-
proach to improve our understanding of the photochemistry of
tetrazole derivatives. In thematrix, the processes are cage-conﬁned
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and molecular diffusion is inhibited, thereby introducing a useful
simpliﬁcation for the investigation of the reaction mechanisms
involved. The main advantage of the matrix-isolation technique is
the possibility to achieve a considerably high spectroscopic resolu-
tion, increasing the probability to detect chemical species produced
in low amounts during photolysis or those with intrinsically low
intensity IR absorptions. Furthermore, due to the high resolution
of the method, it is possible to distinguish spectral signatures
of different tautomers or conformers, usually closely located in
the spectrum, and it becomes possible to compare directly the
experimental spectra with the results of theoretical calculations.
The low temperature conditions can be used for trapping and
spectroscopic identiﬁcation of, at least, some of the intermediate
transient products, which otherwise are very reactive.
2. Experimental methods
1-Phenyl-4-(prop-2-enyl)-tetrazol-5-one (1-phenyl-4-allyl-tetra-
zolone, PAT) was synthesised as described elsewhere.16 The IR
spectra of PAT were obtained using a Mattson (Inﬁnity 60AR
Series) Fourier transform infrared spectrometer, equipped with
a deuterated triglycine sulfate (DTGS) detector and a Ge/KBr
beamsplitter, with 0.5 cm−1 spectral resolution. In order to
avoid interference from atmospheric H2O and CO2, a stream
of dry nitrogen continuously purged the optical path of the
spectrometer. The compound was placed in a specially designed
doubly thermostattable Knudsen cell,22 whose compartments
(sample container and valve nozzle) were kept at 350 K during
deposition of the matrix.Matrices were prepared by co-deposition
onto the CsI substrate of the cryostat cooled to 10 K, of PAT
vapors coming out of the Knudsen cell and a large excess of the
matrix gas (argon N60, Air Liquide) coming from a separate
line. The obtained matrices did not present any evidence for the
presence of associates of the deposited compound.All experiments
were performed using an APD Cryogenics closed-cycle helium
refrigeration system with a DE-202A expander.
Irradiation of the samples was carried out with a 150 W xenon
arc lamp (Osram XBO 150 W/CR OFR), through the outer KBr
window of the cryostat (k > 235 nm).
3. Theoretical calculations
The quantum chemical calculations of the stationary points
were performed at the DFT level of theory using the standard
6-311++G(d,p) basis set and the three-parameter density
functional abbreviated as B3LYP, which includes Becke’s gradient
exchange correction23 and the Lee, Yang, Parr correlation
functional.24 Potential energy scans were performed using the
6-31G(d,p) basis set.
Geometrical parameters were optimized using the Geometry
Direct Inversion of the Invariant Subspace (GDIIS) method.25
Optimization of geometries was followed by calculation of the
vibrational spectra at the same theory level. The nature of the
obtained stationary points was checked through the analysis of
the corresponding Hessian matrix. A set of internal coordinates
was deﬁned, and the Cartesian force constants were transformed
to the internal coordinate space, allowing ordinary normal-
coordinate analysis as described by Schachtschneider,26 by using
the optimized geometries and harmonic force constants resulting
from the DFT(B3LYP)/6-311++G(d,p) calculations.
The calculated harmonic frequencies (scaled with a factor of
0.978)‡ were used to assist the analysis of the experimental spectra
and to account for the zero-point vibrational energy (ZPVE)
corrections. All calculations in this work were carried out using
the Gaussian 03 program.27
4. Results and discussion
The geometry optimisations carried out for 1-phenyl-4-allyl-
tetrazolone (PAT), led to the identiﬁcation of three low energy
localminima, corresponding to the structures Sk′ (“Skew-minus”),
Sk (“Skew-plus”) and Syn, represented as Newman projections in
Fig. 1 (for optimized geometries see the electronic supplementary
information (ESI)).† All these minima depend on the position of
the ethene group on the allylic chain attached to the tetrazole ring,
and their structures result from rotation of this group around
the C(7)–C(8) bond in PAT. The potential energy proﬁle for this
internal rotation (Fig. 1) was calculated by incrementing the value
of the N(4)–C(7)–C(8)=C(9) dihedral angle and fully optimizing all
other geometric parameters. The three low energy conformers Sk′,
Sk and Syn have very close relative energies, which fall in the
0–2.3 kJ mol−1 range (see Fig. 1). At the B3LYP/6-311++G(d,p)
level, the relative energies of Sk′, Sk and Syn were calculated to be
0, 0.2 and 2.2 kJ mol−1, respectively (ZPVE corrections included).
The small differences in the energy of conformers can be explained
considering interactions between the allylic chain and the tetrazole
ring of PAT. In conformer Sk′ (the lowest energy structure) the
ethene group on the allylic chain is as far as possible from the
tetrazole ring and opposite to the carbonyl oxygen O(6), which
minimises repulsive interactions in the molecule and consequently
its energy. Also, in conformer Sk the ethene group on the allylic
Fig. 1 Relaxed potential energy scan for internal rotation of the ethene
group around the C(7)–C(8) bond in 1-phenyl-4-allyl-tetrazolone, calculated
at the DFT(B3LYP)/6-31(d,p) level of theory. The reaction coordinate
was incrementally ﬁxed while all other geometrical parameters were
fully optimized. Minima denoted as Sk′, Syn and Sk correspond to
conformers “Skew-minus”, Syn, “Skew-plus” and are represented as
Newman projections. The lowest-energy structure is conformer Sk′. Its
energy (−681.271842 hartrees) was chosen as the relative zero level.
‡ This scaling factor has been found to provide a good match between cal-
culated and observed spectra of several tetrazole-substituted compounds
we investigated previously.12–15















































chain remains distant from the tetrazole ring, but the closer
proximity of the ethene group to the oxygen atom is responsible
for a slight increase in energy of Sk relatively to the Sk′ form (DE =
0.2 kJ mol−1). The structure Syn is the most unstable conformer
among the three calculated minima, this fact being attributed to
the spatial proximity between the ethene group and the tetrazole
ring.
Calculations show that in all conformers the phenyl and
tetrazole rings have approximately planar geometries and are
coplanar to each other. This last result can be mostly attributed
to the favourable interactions between the phenyl hydrogen atoms
ortho to the tetrazole ring and the carbonyl oxygen and N(2) atoms
(Fig. 1). Structural data for the co-planar phenyl and tetrazolyl
rings in PAT are similar to those observed for 1-phenyltetrazole-
5-one.12 On the other hand, also for all conformers, the geometry
around the N(4)–C(7) bond has been found to be the same, with
the C(8)H=C(9)H2 fragment being perpendicular to the tetrazolone
ring.
Because of the small energy differences between the three
forms, it can be expected that all of them are present in the
gas phase in signiﬁcant amounts. Indeed, at 77 ◦C, the predicted
populations of forms Sk′, Sk and Syn are 41.8%, 38.8% and
19.4%, respectively. The energy barriers separating these forms
were predicted to be higher than 8 kJ mol−1 in both directions
(calculated at the DFT(B3LYP)/6-31G(d,p) level of theory, see
Fig. 1). Although these barriers are not very high, they are related
with rotation of a bulky –CH2–CH=CH2 group. The size of the
group hinders its internal rotation in the rigid environment (low-
temperature matrix) and precludes interconversions between the
three conformers. This implies that the relative populations of the
three conformers of PAT trapped into an Ar matrix should be the
same as they were in the gas phase prior to deposition.28
The experimental IR spectrum of PAT monomers, isolated in
an Ar matrix, is presented in Fig. 2 (trace a). This spectrum is well
reproduced by the spectrum of a conformer mixture simulated
theoretically [at theDFT(B3LYP)/6-311++G(d,p) level, see Fig. 2
(trace b)]. The calculated spectra of the three forms of PAT
are very similar to each other (see the electronic supplementary
information (ESI)),† making very difﬁcult to distinguish these
forms spectroscopically. Luckily, the precise knowledge concern-
ing the conformational orientation of the allyl group (–CH2–
CH=CH2) is not essential for the interpretation of photochemical
transformations of PAT isolated in an argon matrix, as it will be
shown below.
As mentioned above, the photochemistry in solution of a series
of 4-allyl-tetrazolones, including PAT, was recently studied in our
laboratory, revealing that the photolysis in alcoholic solutions
leads to new heterocycles, namely 3,4-dihydro-pyrimidin-2(1H)-
ones, in almost quantitative yields. In the speciﬁc case of PAT
photolysis led to formation of 3,4-dihydro-3-phenylpyrimidin-
2(1H)-one (PDP, Fig. 3). Results from a previous investigation
carried out byQuast and co-workers, under different experimental
conditions, indicated that photolysis of PAT in solution leads to
formation of 1-allyl-1H-benzoimidazol-2(3H)-one (ABZ, Fig. 3)
as the sole product.29 Both primary photoproducts, PDP and
ABZ, detected upon photolysis of PAT in solution, result from
elimination of nitrogen from the tetrazole ring, followed by two
distinct processes of cyclization. The different reactivity revealed in
these two experiments can be attributed to the different method-
ologies used, which clearly affect the reactivity and stability of
the intermediate species involved. The divergent results obtained
for the photolysis of PAT in solution made the photochemical
investigation of this compound in cryogenic matrices an especially
attractive challenge.
Fig. 2 (a) Experimental FTIR spectrum of monomeric 1-phenyl-4-allyl-tetrazolone (PAT) trapped in an argon matrix at 10 K immediately after
deposition; (b) infrared sum spectrum of the characteristic equilibrium mixture of PAT conformers at 77 ◦C. The spectra of individual conformers were
simulated with Lorentzian functions centered at the calculated (scaled) frequencies and with bandwidths-at-half-height equal to 4 cm−1. The calculated
intensities of different conformers were population-weighted; (c) DFT(B3LYP)/6-311++G(d,p) calculated infrared spectrumof themost stable conformer
(Sk′). The calculated wavenumbers were scaled with a uniform factor of 0.978. The calculated intensities were not scaled. For simplicity, only the spectrum
of the most stable form is shown, since the predicted spectra of all conformers are very similar. Spectra of individual conformers are provided in the
electronic supplementary information (ESI).†















































Fig. 3 Proposed photochemical pathways resulting from irradiation of 1-phenyl-4-allyl-tetrazolone (PAT) in an argon matrix through the outer KBr
window of the cryostat (k > 235 nm).
To study the photochemistry of the matrix-isolated PAT, in
situ UV-irradiation (k > 235 nm) experiments were carried out.
The resulting photochemical processes were followed by IR spec-
troscopy and the interpretation of the experimental spectroscopic
data was supported by extensive DFT calculations on plausible
photoproducts, taking into consideration previously reported
spectroscopic data, whenever available.
Upon UV irradiation of matrix-isolated PAT, the intensities
of the bands of this compound decreased signiﬁcantly while
new bands appeared in the infrared spectrum, indicating that
the compound was transformed in diverse photoproducts. The
changes are particularly evident in the 2300–1700 cm−1 spectral
region, which is shown in Fig. 4(A). For the conformationally
ﬂexible photoproducts all conformational possibilities were ex-
plored (about one week of parallel calculations on several PCs).
In the simulated spectra, only the most stable conformers for each
photoproduct were considered (Fig. 4). Further conformers were
neglected in this analysis on the basis that their calculated spectra
are very similar within the same photoproduct. The validity of
such approach is demonstrated by a reasonable correspondence
between the simulated and the observed spectra of photoproducts.
Photochemically induced cleavage of the tetrazole ring has been
found to be a common process.10,11,29–33 As mentioned before,
tetrazole itself easily eliminates molecular nitrogen to produce ni-
trilimine, which then undergoes secondary photoreactions, such as
isomerization to carbodiimide, cyanamide or a hydrogen cyanide–
nitrene complex.10 The proposed reaction pathways resulting from
irradiation of PAT are schematically shown in Fig. 3.
The photochemistry of the matrix-isolated compound reveals
three main reaction pathways: (1) cleavage of the tetrazole ring
through the formally single bonds C(5)–N(1) and N(3)–N(4), with
production of phenylazide and allyl-isocyanate as primary pho-
toproducts (phenylazide can then undergo additional reactions to
give 1-aza-1,2,4,6-cycloheptatetraene); (2) cleavage of theN(1)–N(2)
andC(5)–N(4) bonds, leading to formation of phenyl-isocyanate and
allylazide, and (3) cleavage of theN(1)–N(2) andN(3)–N(4) bonds pro-
ducing 1-allyl-2-phenyldiaziridin-3-one (APD). This compound
is then partially transformed in 1-allyl-1H-benzoimidazol-2(3H)-
one (ABZ).
The possible formation of PDP from PAT, shown by the
Pathway “0” in Fig. 3, was found not to occur under the present
experimental conditions, contrarily to what was observed during
the photolysis of PAT in solution. The designation of Pathway
“0” illustrates that the outcome of this channel in the argon
matrix at 10 K is equal to 0%. The non-formation of PDP in
this study is doubtlessly related to the matrix medium where the
reaction is suppressed. We believe that a strong restriction of
conformational mobility in the argon matrix affects not only PAT
itself (see above), but also its photoproducts. The design of PDP
from PAT (after extrusion of N2) involves an approach between
the terminal carbon of the allylic chain and the nitrogen atom
N(1), in order to form a new C–N single bond. Such approach
is strongly hindered in the rigid matrix, which consequently
precludes formation of PDP. The inclusion of the hypothetic
reaction channel leading to PDP in the general scheme presented
in Fig. 3 results from the initial assumption that this could be a
possibility, in view of the results obtained in solution. For the sake
of simplicity, the calculated spectrum of PDP is omitted in part B
of Fig. 4.
The observed photoprocesses in the argon matrix (Pathways 1
to 3 in Fig. 3) result from cleavage of the four formally single bonds
in different combinations, whereas every primary photoreaction















































Fig. 4 Infrared spectra of 1-phenyl-4-allyl-tetrazolone (PAT) and the proposed photoproducts, in the carbonyl stretching (A) and ﬁngerprint (B)
regions. Upper frames (EXPERIMENT): dashed line—FTIR spectrum of monomeric PAT trapped in an argon matrix at 10 K immediately after
deposition (0 min of irradiation); solid line—extracted spectrum of the photoproducts formed after 40 min of UV-irradiation (k > 235 nm) of PAT
trapped in an Ar matrix. The extracted spectrum was obtained by subtraction of the scaled spectrum of non-irradiated matrix from the spectrum of
irradiated sample. The scaling factor was chosen so that the absorptions due to the originally deposited compound (PAT) were nulliﬁed. Lower frames
(CALCULATION): DFT(B3LYP)/6-311++G(d,p) calculated spectra of PAT (dashed sticks) and possible photoproducts. The calculated wavenumbers
were scaled with a uniform factor of 0.978. The calculated intensities were not scaled. Groups [1], [2] and [3] designate different photochannels. Middle
frames (SIMULATION): simulated infrared spectra of PAT (dashed line) and amixture of photoproducts (solid line). They were created using Lorentzian
functions centered at the calculated (scaled) frequencies (shown in the lower frames) and with bandwidths-at-half-height equal to 4 cm−1. The calculated
intensities in the spectrum of PAT were taken as 100%. The calculated intensities of photoproducts were scaled down to reproduce the relative intensities
in the experimental spectrum of photoproducts in the carbonyl stretching region (part A) and to obey the normalization condition: total amount of
photoproducts is equal to the amount of consumed reagent (48%). Note that in the ﬁngerprint region (part B), the experimental (upper frame) and
simulated (middle frame) spectra of PAT (dashed lines) are shifted on ordinate for clarity. The symbols of PAT and photoproducts are the same in parts
A and B.
involves cleavage of two single bonds in the tetrazole ring. After
40 min of UV-irradiation, the amount of the consumed reagent
is equal to 48%. This percentage should then correspond to the
sum of efﬁciencies of the three reaction pathways and to the total
amount of photoproducts.
All strong and medium intensity bands calculated for the two
primary photoproducts formed in Pathway 1 (phenylazide and
allyl-isocyanate) could be observed in the spectra of the irradiated
matrix (see Fig. 4). The experimental spectrum of aliphatic
isocyanates, such as allyl-isocyanate, is usually easily identiﬁable,
because it shows an intense vibration in the 2290–2300 cm−1 region
due to the mN=C=O antisymmetric stretching vibration. In the
spectrum of photoproducts (Fig. 4(A)) the band associated to
this vibration emerges at 2296.5 cm−1, proving formation of allyl-
isocyanate upon PAT photolysis.
Pathway 1 shows a secondary process resulting from conver-
sion of phenylazide in 1-aza-1,2,4,6-cycloheptatetraene (ACHT).
Phenylazide has been previously isolated and irradiated in an ar-
gonmatrix, and its conversion into ACHT clearly demonstrated.12
The vibrational spectra of matrix isolated phenylazide34 and of















































ACHT are well known and their identiﬁcation was made without
any difﬁculty. In the spectrum of the photoproducts, the most
prominent band of phenylazide appears at 2108.8 cm−1 and is
ascribed to the mN=N+=N− antisymmetric stretching vibration.
Characteristic bands of ACHT12 were also clearly identiﬁed in
the spectra of the irradiated matrix. Particularly evident is the
band-mark associated with the intense antisymmetric stretching
vibration of the ketenimine moiety (mC=C=N as.) of ACHT,
observed at 1910.5 cm−1 (Fig. 4).
The efﬁciencies of the different photochannels were estimated
on the basis of the comparisonbetween the relative band intensities
for the photoproducts observed experimentally. These intensities
were pre-normalized by the calculated intensities of the putative
photoproducts, using the observed and calculated absorptions in
the 1600–2400 cm−1 spectral region (see Fig. 4(A)). According
to the available literature data, the average absolute difference
in the intensities calculated using the applied theoretical method
and basis set can be estimated to be ca. 6 km mol−1, the
method showing a performance in close agreement with the high-
level QCISD ab initio method.35 All the photoproduct bands
in the used spectral range have absolute calculated intensities
in the range 200–1500 km mol−1 (see Fig. 4(A)). This leads to
expected uncertainties below 3% in the calculated frequencies. A
subsequent normalization was carried out in order to bring the
total efﬁciency of all photochannels to be equal to the amount
of consumed reagent (i.e. 48% after 40 min). The validity of this
normalization procedure was then conﬁrmed in the ﬁngerprint
region of spectrum (see Fig. 4(B)), which provided a very nice
correspondence between the simulated (middle frame) and the
observed (upper frame) spectra.
We found that the transformation of PAT into allyl-isocyanate
and phenylazide proceeds with low efﬁciency. Allowing for 48% of
consumed reagent, only 8% (i.e. 1/6) is attributed to the reaction
Pathway 1. On the other hand, the secondary transformation
of phenylazide into ACTH was carried out with relatively high
efﬁciency. Three quarters of the 8% attributed to this reaction
channel were converted into ACHT [(Ph-NNN 2%) + (ACHT,
6%) = 8%].
Reaction Pathway 2 represented in Fig. 3 corresponds to
tetrazole ring-opening leading to allylazide and phenyl-isocyanate
as photoproducts. In the experimental spectrum of the photo-
products, the band that appears at 2085.6 cm−1, in close proximity
to the corresponding band for phenylazide, is ascribed to the
mN=N+=N− antisymmetric stretching vibration of allylazide. The
spectrum of phenylisocyanate in solid argon has been reported,12
and is easily identiﬁable because it shows a very intense vibration
in the 2290–2260 cm−1 region, due to the N=C=O antisymmetric
stretching, that dominates the spectrum. In the spectrum of
photoproducts (Fig. 4(A)) this vibration emerges as a doublet
at 2280.3/2265.3 cm−1 clearly demonstrating the formation of
phenyl-isocyanate.
The conversion of PAT into phenyl-isocyanate and allylazide
proceeds with relatively high efﬁciency. Considering the total
amount of consumed reagent (48%), 16% (i.e. 1/3) is attributed to
the reaction Pathway 2. Moreover, there is no indication that the
compounds formed in this channel undergo additional reactions.
Photochemical Pathway 3 in PAT corresponds to a [3 + 2]
pericyclic molecular nitrogen elimination reaction, which leads
to formation of a three-membered heterocyclic ring, namely the
1-allyl-2-phenyldiaziridin-3-one (APD) (see Fig. 3). To the best of
our knowledge, this species was never described before.
Recently, we have described the photo-induced elimina-
tion of molecular nitrogen from 1-phenyl-tetrazolone to give
phenyldiaziridin-3-one.12 Diaziridinones can be easily identiﬁed
because theirmost intense IRband, corresponding to a vibrational
mode with dominant contributions from the mC=O and mC–N
antisymmetric coordinates, occurs in a “clean” region of the
spectrum (1900–1850 cm−1). In the spectra of the irradiatedmatrix,
the band corresponding to this vibrational mode was clearly
identiﬁed at 1883.2 cm−1 (Fig. 4(A)), conﬁrming the formation
of APD upon PAT photolysis.
Pathway 3 shows a secondary process resulting from conversion
of APD into 1-allyl-1H-benzoimidazol-2(3H)-one (ABZ). In
the spectra of the photoproducts, the band that appears at
1735.2 cm−1, overlapped with the doublet at 1746.0/1740.9 cm−1
due to the mC=O antisymmetric stretching vibration of PAT, is
attributed to the similar vibration (mC=O) in ABZ (Fig. 4(A)).
Alternative attributions/photoproducts for the band registered
at 1735.2 cm−1 were investigated, but all of them were rapidly
discarded. The validity of this attribution is conﬁrmed by a good
correspondence between the simulated and the observed spectra
of ABZ. Furthermore, it was found that the transformation of
PAT in APD plus ABZ occurs with a high efﬁciency. Allowing for
the total amount of consumed reagent (48%), 24% is attributed to
the reaction Pathway 3.
On the other hand, the secondary transformation of APD into
ABZ was carried out with relatively low efﬁciency (from 24%,
only 8% (i.e. 1/3) was converted in ABZ). APD has a high
conformational mobility, but only some part of conformers has a
favorable spatial orientation wherein the close proximity of the
phenyl and imidazole rings is not affected by the position of
allylic fragment and ABZ formation is possible. The restriction
of conformational mobility in the matrix can then justify the low
yield observed for this secondary transformation.
Interestingly, the allylic chain is maintained unbroken during
the irradiation process, indicating that under the experimental
conditions used this unit is photochemically stable. Finally, consid-
ering the efﬁciencies of the different reaction channels discussed,
a remarkable relationship between their values is detected. The
sequence “0 : 8 : 16 : 24” (%), associated to the efﬁciencies of
Pathways 0 to 3 respectively, can be related as “0 : 1 : 2 : 3” as a
perfect and interesting sequence. This is certainly accidental, but
still a good example of how Nature can be proud of symbolic
beauty!
5. Conclusions
The photochemistry of the matrix-isolated 4-allyl-1-phenyl-
tetrazolone (PAT) has been investigated and is now described.
The structures of the initial compound and of the photoprod-
ucts were determined by infrared spectroscopy, supported by
high-level quantum chemical calculations. The DFT(B3LYP)/6-
311++G(d,p) calculations performed in this study predict that, in
the gaseous phase, PAT should exist in three different conformers,
depending on the position of the ethene group on the allylic chain
attached to the tetrazole ring. The potential energy proﬁle for
internal rotation of the ethene group was calculated, revealing that
the energy barriers separating the three conformers are higher than















































8 kJ mol−1. These barriers are not very high, but they are related
with rearrangements of a bulky allyl fragment, which is unlikely
to occur in the matrix and thus prevent interconversions between
the three conformers. Consequently, the experimental spectrum of
PAT closely matches the infrared sum spectrum of the equilibrium
mixture of PAT conformers predicted theoretically, pointing to the
existence of the three structures in the low-temperature matrix.
The exposure of matrix-isolated PAT to the UV (k > 235 nm)
light has been shown to induce three different photochemical
pathways: Pathway 1: production of phenylazide and allyl-
isocyanate as primary photoproducts; Pathway 2: production
of phenyl-isocyanate and allylazide; and Pathway 3: molec-
ular nitrogen elimination, leading to formation of 1-allyl-2-
phenyldiaziridin-3-one (APD). The primarily formed phenylazide
(Pathway 1) and APD (Pathway 3) are partially converted
into 1-aza-1,2,4,6-cycloheptatetraene (ACHT), and 1-allyl-1H-
benzoimidazol-2(3H)-one (ABZ) respectively. Both the vibra-
tional characterisation of APD and the observation of its infrared
spectrum were carried out for the ﬁrst time. The combination of
the matrix isolation technique coupled to the FT-IR spectroscopy
and aided by theoretical calculations has permitted to identify
the photoproducts produced upon photolysis of PAT monomers
isolated in an argon matrix.
The non-occurrence (pathway 0) or a partial occurrence (path-
way 3) in the matrix of the photoreactions involving conforma-
tional mobility (and efﬁcient elsewhere in solutions) provided
further evidence of the restricted conformational mobility of the
studied system in the matrix.
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